glp 1 and gip receptors Receptor Agonism Attenuates GLP-1 Receptor Agonist Induced Nausea Emesis in Preclinical Models — Hayes Lab Major physiological roles of GLP-1

A regulatory challenge arguing that the FDA's interpretation of 503A is too narrow is theoretically possible but faces long odds given the statute's plain language

Marso SP, Bain SC, Consoli A, et al

Access is Becoming More Prohibitive About one in five U.S

If a GC must be administered to an athlete by a prohibited route, during the in-competition period* then a Therapeutic Use Exemption is required

Biochemical outcomes Glucose There was a significant reduction in fasting plasma glucose (FPG) in the inulin group compared to control at week nine (0.23 0.17 mmol/L, n = 20 vs 0.44 0.24 mmol/L, n = 19, p = 0.005) after controlling for weight loss but the change at week 18 was no longer significant (0.40 0.19 mmol/L, n = 20 vs 0.16 0.23 mmol/L, n = 18, p = 0.08) (Fig